New-to-market dry eye treatment device, E-Eye, is now available on a rental scheme through its distributor Grafton Optical.
The E-Eye device uses patented IRPL (Intense Regulated Pulsed Light) technology designed for the treatment of dry eye due to Meibomian gland dysfunction (MGD). The pulsed light regenerates the glands to improve the quality of secretions.
The company said in most cases, dry eye symptoms would significantly improve after three sessions, carried out over 45 days. For 60% of patients, results can last up to three years.
Brian Bowles, managing director of Grafton Optical said: ‘We have seen huge interest and success with the E-Eye since its launch in the UK last year. It offers huge benefits not only to patients suffering from MGD-related Dry Eye but also to practices wishing to increase their income.’